|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent INSM insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why INSM insider buys are important for investors to follow.
Date | Insider | Price | Amount |
5-15-2023 Insider Buy |
Melvin Sharoky, M.D. Director |
$19.29
CAGR »
|
$385,800.00 20,000 shares |
11-1-2022 Insider Buy |
Melvin Sharoky, M.D. Director |
$17.59
CAGR »
|
$527,600.00 30,000 shares |
10-31-2022 Insider Buy |
Leo Lee Director |
$17.69
CAGR »
|
$796,050.00 45,000 shares |
5-11-2022 Insider Buy |
Melvin Sharoky, M.D.
|
$17.20
CAGR »
|
$344,000.00 20,000 shares |
11-1-2021 Insider Buy |
David R. Brennan
|
$30.15
CAGR »
|
$301,500.00 10,000 shares |
11-1-2021 Insider Buy |
Steinar J. Engelsen
|
$30.14
CAGR »
|
$429,042.90 14,235 shares |
3-4-2021 Insider Buy |
Steinar J. Engelsen
|
$36.90
CAGR »
|
$99,999.00 2,710 shares |
11-12-2018 Insider Buy |
Melvin Sharoky, M.D. Director |
$16.01
CAGR »
|
$320,211.40 20,000 shares |
11-1-2018 Insider Buy |
Roger Adsett Chief Commercial Officer |
$15.97
CAGR »
|
$47,907.00 3,000 shares |
11-1-2018 Insider Buy |
Steinar J. Engelsen Director |
$15.79
CAGR »
|
$253,993.41 16,085 shares |
5-31-2017 Insider Buy |
Christine A. Pellizzari General Counsel & Corp. Sec. |
$15.14
CAGR »
|
$151,382.00 10,000 shares |
12-15-2016 Insider Buy |
Christine A. Pellizzari General Counsel & Corp. Sec. |
$12.80
CAGR »
|
$256,100.00 20,000 shares |
8-13-2014 Insider Buy |
Melvin Sharoky, M.D. Director |
$11.25
CAGR »
|
$1,000,001.25 88,889 shares |
11-1-2013 Insider Buy |
William Lewis President and CEO |
$14.28
CAGR »
|
$74,727.24 5,233 shares |
7-1-2013 Insider Buy |
William Lewis President and CEO |
$9.83
CAGR »
|
$74,547.40 7,585 shares |
4-1-2013 Insider Buy |
William Lewis President and CEO |
$7.58
CAGR »
|
$74,405.28 9,816 shares |
1-9-2013 Insider Buy |
William Lewis President and CEO |
$6.90
CAGR »
|
$74,313.00 10,770 shares |
12-3-2012 Insider Buy |
William Lewis President and CEO |
$7.36
CAGR »
|
$99,860.48 13,568 shares |
6-14-2012 Insider Buy |
Melvin Sharoky, M.D. Director |
$3.00
CAGR »
|
$59,808.00 19,936 shares |
6-1-2012 Insider Buy |
Timothy Whitten President & CEO |
$2.91
CAGR »
|
$21,790.50 7,500 shares |
Also See: Institutional Holders of INSM
Also See: SEC filings
Below we present the annualized performance delivered by INSM stock since 5-15-2023 (the date of the most recent
insider purchase). The performance of the investment from the time INSM insider buying occurred is the ultimate
test of whether insiders were right about INSM being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/16/2023 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$18.38 |
|
End price/share: |
$24.80 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
34.93% |
|
Annualized Gain: |
37.72% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$13,493.00 |
|
Years: |
0.93 |
|
INSM Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent INSM insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding INSM
|
|